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Abstract 
Background: Early detection of pediatric HIV through uptake of infant HIV testing is critical for access to treatment 
and child survival. While structural barriers have been well described, a greater understanding of social and behavioral 
factors that may relate to maternal uptake of early infant HIV testing services is urgently needed. The aim of this study 
was to explore how gender power dynamics within couples affect HIV-positive women’s uptake of early infant HIV 
testing at a large health center in Lusaka, Zambia.
Methods: In 2014, 320 HIV-positive married postpartum women were recruited at a large public health facility in 
Lusaka to participate in a cross-sectional survey. Data on uptake of early infant HIV testing by 4–6 weeks of age was 
collected through medical records. Simple and multiple logistic regression models determined significant predictors 
of maternal uptake of early infant HIV testing.
Results: In the adjusted model, uptake of early infant HIV testing was associated with female-directed emotional 
intimate partner violence (aOR 0.41; 95% CI 0.21–0.79; p < 0.01), HIV status disclosure to the male partner (aOR 13.73, 
95% CI 3.59–52.49, p < 0.001), and maternal postpartum ART adherence (aOR 2.28, 95% CI 1.15–4.55, p < 0.05).
Conclusions: Domestic relationship dynamics, including emotional violence and HIV status disclosure to the male 
partner, may play an important role in maternal uptake of early infant HIV testing. These findings provide additional 
evidence for the link between intimate partner violence against women and poor HIV-related health outcomes. 
Programs that adequately screen for and address various forms of intimate partner violence within the context of 
prevention of mother-to-child transmission are recommended.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Despite commendable advances in prevention of mother-
to-child transmission (PMTCT), pediatric HIV remains 
a significant public health challenge, particularly in sub-
Saharan Africa. In 2015, 150,000 children under 15 years 
of age were newly infected with HIV and 1.8 million chil-
dren were living with the virus—the majority residing in 
sub-Saharan Africa [1]. In the study setting, Zambia, an 
estimated 85,000 children were living with HIV in 2015 
[2]. Early detection of HIV in infants through timely HIV 
testing is critical for their survival due to the increased 
risk of mortality without antiretroviral therapy (ART) 
compared to HIV-infected adults [3–5]. The World 
Health Organization (WHO) currently recommends test-
ing of HIV-exposed infants in resource-limited settings 
using dry blood spot (DBS) polymerase chain reaction 
(PCR) technology at 4–6 weeks of life to optimize detec-
tion of intrauterine, intrapartum, and early postnatal 
mother-to-child HIV transmission [6]. Yet, most recent 
estimates indicate that less than half of the infants born 
to HIV-positive mothers in low- and middle-income 
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countries receive an HIV test within the first two months 
of life [7].
Numerous healthcare system barriers to early diag-
nosis of HIV infection in infants in resource-limited 
settings have been identified. For example, DNA-PCR 
using DBS requires sophisticated and expensive nucleic 
acid testing, as well as highly trained staff and advanced 
laboratory infrastructure, which is generally only pre-
sent in large, centralized laboratories [8–10]. Indeed, in 
Zambia, there are only three facilities with laboratories 
capable of processing PCR [11]. The situation is also 
exacerbated by restriction of sample collection sites to 
PMTCT clinics, stock outs of HIV testing commodities, 
poorly functioning sample transport networks, and lim-
itations in supply chain management [8, 12, 13]. Current 
efforts are underway to address these acknowledged 
problems, including, for example, point-of-care tech-
nologies [12].
While healthcare system barriers related to infant HIV 
testing have been well described, less is known about the 
impact of social factors, including dynamics with the 
male partner, among HIV-positive mothers. The fam-
ily—particularly the male partner—is arguably the most 
influential social unit affecting individual health behav-
iors [14]. In African settings in particular, male partners 
are known to play an essential role in household deci-
sion-making, including women’s use of HIV-related ser-
vices [15–17]. Moreover, dynamics with male partners, 
such as HIV status disclosure and fear of intimate part-
ner violence (IPV), are known to effect women’s uptake 
of some services in the PMTCT cascade of care [18, 19]. 
It is plausible that the same barriers related to dynam-
ics within couples that exist for other PMTCT-related 
health behaviors may prevent HIV-positive mothers from 
accessing early infant HIV testing services. This study 
explores how gender power dynamics within couples, 
such as IPV against women and male controlling behav-
iors, women’s participation in household decision-mak-
ing, and women’s relative earnings, as well as HIV status 
disclosure to male partners, affect HIV-positive mother’s 
uptake of early infant HIV testing by the recommended 




A cross-sectional survey was conducted with postpar-
tum HIV-positive women who were currently married 
or cohabiting with a male partner. Recruitment occurred 
at a large public health center during routine pediatric 
immunizations from April to August of 2014. Quantita-
tive data were collected through medical records (i.e., the 
child’s Under-Five Card) and a face-to-face survey with 
closed-ended questions, including dynamics within the 
woman’s current heterosexual relationship. The question-
naire was pretested during a pilot study in March of 2014. 
Trained Zambian research assistants verbally adminis-
tered the survey in the local languages on paper forms 
in a private location at the health center after women 
completed their health care visit. The questionnaire was 
written in English, but translated into the two most com-
monly spoken dialects in Lusaka (Nynaja and Bemba). 
Participants received a small travel reimbursement for 
their time. Written informed consent or a thumbprint 
was obtained from all study participants. The study was 
designed and implemented in accordance with the WHO 
Ethical and Safety Recommendations for Research on 
Domestic Violence Against Women [20]. Research Assis-
tants were trained in research ethics. Participants who 
reported IPV were offered referrals to a local organiza-
tion for counseling and victim support services.
Study participants
Participants included 320 HIV-positive mothers who had 
brought their child for routine pediatric immunizations 
in the Maternal and Child Health Department of a large 
public health center in Lusaka, Zambia. The health center 
has a catchment population of over 160,000 individuals 
living in the surrounding low socioeconomic neighbor-
hoods. Mothers who were diagnosed as HIV seroposi-
tive, over the age of 18 years, currently married or living 
with a man as if married, and whose youngest biological 
infant was between 3 and 9 months of age were invited 
to participate in the survey after completing their health 
care visit. Infant age criterion was selected based on the 
immunization schedule in Zambia and to limit recall 
bias. Immunization compliance in Zambia is high with 
97% of all infants receiving at least some immunizations 
by 12 months of life [15–17].
Nurses determined eligibility for the study using the 
infant’s “Under-Five Card,” a mother’s copy of her child’s 
health record that she is required to bring to all pediat-
ric health care visits and includes the child’s birth date, 
height and weight, immunizations, medications, and 
PMTCT care. Nurses providing immunizations exam-
ined the Under-Five Card or other medical records if 
the card was not available and verbally invited eligible 
women to participate in the survey by proceeding to a 
designated private room (or waiting area outside if the 
room was occupied) in the clinic where research assis-
tants conducted informed consent, asked additional 
screening questions, and verbally administered the sur-
vey questionnaire to consenting eligible participants. The 
response rate for eligible women was 85%.
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Measures
The main outcome of interest, uptake of infant HIV test-
ing by 4–6  weeks postpartum, was captured using the 
child’s Under-Five Card or other available medical record. 
Research assistants indicated on the survey questionnaire 
whether the child had record of HIV testing at 4–6 weeks 
via PCR, and if available, the result of the test. Gender 
power dynamics within the couple, the independent vari-
ables of interest, were measured using the Revised Con-
flict Tactics Scale (CTS2). The CTS2 is one of the most 
widely used gender power measurement tools worldwide 
with strong reported psychometric properties [21]. The 
version of the CTS2 used in this study came directly from 
the Zambian Demographic and Health Survey (ZDHS) 
Domestic Violence Module [22, 23]. The DHS Domes-
tic Violence Module was first developed and standard-
ized in 2000 and has been continually used throughout 
sub-Saharan Africa [24]. The module includes ques-
tions regarding different forms of IPV against women, 
male partner controlling behaviors, women’s participa-
tion in household decisions, and women’s relative earn-
ings. Participants were asked to report their experiences 
with specific emotional, physical, and sexual IPV events 
ever occurring in the course of their relationship with 
the current male partner. There were three possible spe-
cific events for emotional violence, seven possible events 
for physical violence, and two possible events for sexual 
violence. Participants also reported whether their male 
partner displays specific controlling behaviors from a set 
of six questions. In addition, the survey included four 
questions regarding women’s participation in household 
decisions regarding daily household purchases, major 
household purchases, women’s use of health care, and 
the final say over how money is spent. Women’s relative 
earnings compared to the husband was measured by ask-
ing women if the they earn more money than the hus-
band, about the same amount of money, or less money 
than the husband. We also added one additional question 
on women’s HIV status disclosure to the husband.
Control variables included the woman’s age, infant’s 
age, parity, education, household wealth (a proxy for 
socioeconomic status), when the woman was diagnosed 
with HIV (before or during the most recent pregnancy), 
if the woman was taking lifelong triple ART or short 
course prophylaxis under WHO Option A, knowledge 
of PMTCT, the woman’s postpartum ART adherence, 
and the male partner’s HIV status (positive, negative, 
or unknown). Educational attainment was measured 
by asking women “what was the highest level of school 
you attended” (none, some primary, completed primary, 
some secondary, completed secondary, some college, 
completed college, or graduate level). We measured soci-
oeconomic status by asking participants what household 
assets their home owned from a list of 21 possible items, 
including, for example, electricity, a car, and a refrigera-
tor. Knowledge of PMTCT was measured by asking par-
ticipants “are there any special drugs that a doctor or 
nurse can give to a woman infected with HIV to reduce 
the risk of transmission to the baby?.” Lastly, postpartum 
ART adherence was measured using a visual analog scale 
(VAS) [25] that was verbally explained to women by the 
research assistants. Participants retrospectively reported 
on their estimate of ART adherence (doses taken at the 
appropriate time) since giving birth from 0 to 100%. Post-
partum adherence rather than pregnancy adherence was 
included in our analysis because the time period more 
closely correlates with maternal uptake of infant HIV 
testing behaviors.
Data cleaning and statistical analysis
Survey data were double entered into CSPro and 
exported into Stata 12 for analysis. Surveys with more 
than 50% missing data were not included in the analyses 
(n =  4). Missing data (2.3%) were imputed using multi-
variate chained equations in Stata 12 [26, 27]. Data con-
verged, indicating that the multivariate chained model 
was a good fit for the data set [28]. We created a binary 
dependent variable for uptake of early infant HIV test-
ing based on whether or not a PCR test was specified on 
the child’s health record/Under-Five Card by 4–6 weeks 
of age. For the independent variables regarding dynamics 
with the male partner, we created two binary variables to 
capture experiences with IPV: 1) if the woman reported 
any female-directed emotional IPV in the course of the 
relationship and 2) if the woman reported any female-
directed physical/sexual IPV in the course of the relation-
ship. We also created a binary variable to capture if the 
male partner displayed three or more controlling behav-
iors based on prior literature standards for analyzing 
this variable [24]. Additionally, we created a count vari-
able to indicate the number of household decisions (0–4) 
women reported participating based on their responses 
to the individual household decision-making questions. 
Women were categorized as participating in a household 
decision if they made the decision alone or together with 
the male partner,  compared to when the male partner 
alone makes the decision. For women’s relative earnings, 
we created a binary variable to indicate whether women 
make more/about the same amount of money as the hus-
band, compared to women who make less money than 
the husband. Lastly, a binary variable for status disclosure 
was created to capture whether women reported notify-
ing their male partner of their HIV-positive status.
For the control variables, the woman’s age and parity 
were treated as continuous variables in the analysis. Two 
variables based on reported educational attainment were 
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created: if the woman completed primary education and 
if the woman completed secondary education. For socio-
economic status, we converted women’s responses to the 
list of household assets into a linear index using princi-
pal-components analysis (PCA) to derive weights [29]. 
For example, if a household had electricity, it would move 
the participant 0.30 on the index; however, if a household 
owned a chair, it would only move the participant 0.17 on 
the index. The index was standardized prior to inclusion 
in the regression models. Additional binary control vari-
ables included: whether the woman was diagnosed with 
HIV during the most recent pregnancy, whether she was 
taking lifelong triple ART, and whether she had knowl-
edge regarding PMTCT. Postpartum ART adherence was 
dichotomized into a variable indicating if the woman was 
at least 80% adherent to taking medication after giving 
birth based on recent studies suggesting this is the ade-
quate doses needed to suppress the virus [30, 31]. Finally, 
three dummy variables were created to indicate the male 
partner’s HIV status: (1) if the male partner was HIV-
positive, (2) if the male partner had an unknown status 
or never tested for HIV, and (3) if the male partner was 
HIV-negative.
Descriptive statistics highlighted sample characteris-
tics stratified by if the child had an early HIV test. Simple 
logistic regression models determined significant differ-
ence in the odds of early infant HIV testing by the inde-
pendent variables of interest and control variables. We 
also ran a pairwise correlation to determine the correla-
tion coefficients for experiencing any emotional IPV in 
the course of the relationship, the number of household 
decisions the woman participates, and if the male partner 
displays 3 or more controlling behaviors. These gender 
power variables were selected for the correlation analy-
sis because they were significantly associated with early 
infant HIV testing in the bivariate model. Each measure 
in the correlation analysis was highly correlated with 
the other (p < 0.001), indicating a significant interaction 
between these variables.
Finally, a multiple logistic regression model deter-
mined significant differences in the odds of early infant 
HIV testing by the relevant independent variables (i.e., 
those associated with the dependent variable in the 
simple logistic regression models) after adjusting for 
control variables of age, parity, whether the woman com-
pleted secondary education, whether she was diagnosed 
with HIV during the most recent pregnancy, household 
wealth index, postpartum ART adherence, and the hus-
band’s HIV status. Secondary education, rather than 
primary education, was included in the multiple logistic 
regression models because it displayed greater variabil-
ity in the sample. The variables capturing knowledge of 
PMTCT, if the woman was taking lifelong triple ART, any 
female-directed physical/sexual IPV, and if the woman 
had greater or equal earnings as male partner were 
not included in the multiple logistic regression model 
because they were not significantly associated with early 
infant HIV testing in the simple logistic regression mod-
els and have not previously been established in the litera-
ture as important covariates.
Results
Participant characteristics
Table 1 displays the participant characteristics, compar-
ing infants who had an early HIV test and those who did 
not. Of the 320 HIV-positive female participants, the 
median age was 28 years (IQR 24, 34). Women had given 
birth to a median of 3 children (IQR 2, 4). Over 70% of 
women had completed primary education, but only 14% 
had completed secondary education. For the poorest 40% 
of the sample, the mean wealth index score was −1.97. 
For the mid-wealth participants (also 40% of the sample), 
the mean wealth index score was 0.88. For the wealthiest 
20% of the sample, the mean wealth index score was 2.67. 
In terms of actual household assets, 75% of participants 
had electricity; 39% owned a refrigerator, and 5% owned 
a vehicle. Knowledge of PMTCT was nearly universal: 
96% of women agreed that there are special drugs that 
can prevent mother-to-child HIV infection. The major-
ity of participants (60%) reported being diagnosed with 
HIV during the most recent pregnancy while 40% knew 
their status prior to becoming pregnant. Fifty-six percent 
of participants were prescribed lifelong triple ART while 
44% were not eligible for treatment and taking short-
course prophylaxis under WHO programmatic Option 
A. Lastly, 81% of women reported being adherent to ART 
postpartum.
Disclosure of women’s HIV status to the male part-
ner was high with 92% of women reporting they had 
informed the current partner of their HIV-positive status. 
Approximately half (52%) of the participants’ reported 
having a male partner who is also living with HIV (i.e., 
seroconcordant), 28% reported having a male partner 
who is HIV-negative (serodiscordant), and 21% reported 
having a male partner whose status was unknown or who 
had never tested for HIV. Experiences with IPV were 
common: 40% of women reported any female-directed 
emotional IPV in the course of the relationship and 50% 
of women reported any female-directed physical/sexual 
IPV in the course of the relationship. Male controlling 
behaviors were also common with 56% of women report-
ing their male partner displays three or more controlling 
behaviors. Women reported participating in a median of 
half (2.0 out of 4.0) of the household decisions. Twenty-
five percent of women reported having equal or greater 
earnings as the male partner.
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Uptake of early infant HIV testing and unadjusted 
associations
Seventy-three percent (n =  233) of infants had an HIV 
test by 4–6 weeks of age. Table 1 indicates which demo-
graphic and sexual relationship characteristics were 
associated with uptake of early infant HIV testing in the 
simple logistic regression models. Two demographic 
characteristics were associated with uptake of early infant 
HIV testing in the bivariate models: knowing one’s HIV 
status prior to becoming pregnant (p  <  0.05) and being 
adherent to postpartum ART (p < 0.001). Sexual relation-
ship characteristics associated with uptake of early infant 
HIV testing included: HIV status disclosure to the male 
partner (p  <  0.001), having an HIV-positive male part-
ner (p < 0.05) and knowing the male partner’s HIV status 
(p  <  0.05), not experiencing any female-directed emo-
tional IPV (p  <  0.001), the male partner displaying <3 
controlling behaviors (p < 0.05), and greater participation 
in household decision-making (p < 0.01).
Uptake of early infant HIV testing and adjusted 
associations
Table 2 displays the multiple logistic regression results for 
the adjusted odds of early infant HIV testing by dynam-
ics within the couple and control variables. The only 
power dynamic that remained significantly associated 
with uptake of early infant HIV testing after including 
other gender power measures and control variables was 
female-directed emotional IPV: women who reported 
any female-directed emotional IPV in the course of their 
Table 1 Participant Characteristics (n = 320)
a Comparison group: prescribed short-course prophylaxis under Option A
b Defined as the woman’s self-report of taking >80% of medication doses postpartum (includes both short-course prophylaxis and lifelong triple ART)
c Out of six total behaviors
d Out of four total household decisions
Variable Infant tested by  
4–6 weeks (n = 233)
Infant not tested 
by 4–6 weeks (n = 87)
Total (n = 320)
Median (IQR)/N (%) Median (IQR)/N (%) Median (IQR)/N (%) P
Demographic characteristics
 Age in years 29.0 (25.0, 34.0) 27.0 (24.0, 33.0) 28.0 (24.0, 34.0) 0.097
 Parity 3.0 (2.0, 5.0) 3.0 (2.0, 4.0) 3.0 (2.0, 4.0) 0.161
 Completed primary education 167 (72.8%) 63 (72.2%) 230 (71.9%) 0.572
 Completed secondary education 35 (15.3%) 9 (11.4%) 44 (13.8%) 0.187
 Standardized wealth Index 0.14 (−0.73, 0.89) −0.08 (−0.83, 0.59) 0.06 (−0.78, 0.76) 0.106
 Diagnosed with HIV during most recent 
pregnancy
130 (55.9%) 63 (72.0%) 192 (60.3%) 0.010
 Prescribed lifelong triple ARTa 138 (59.1%) 41 (47.7%) 179 (56.0%) 0.068
 Knowledge of PMTCT 225 (96.5%) 81 (93.0%) 306 (95.6%) 0.183
 Adherent to ARTb 202 (86.8%) 57 (65.1%) 259 (80.9%) 0.000
Sexual relationship characteristics
Disclosed HIV status to male partner 227 (97.6%) 66 (76.0%) 293 (91.8%) 0.000
 Male partner HIV status
  Positive (seroconcordant) 128 (55.2%) 36 (41.9%) 164 (51.6%) 0.036
  Negative (serodiscordant) 65 (27.8%) 24 (27.6%) 89 (27.8%) 0.980
  Unknown/partner not tested 40 (17.0%) 26 (30.5%) 66 (20.6%) 0.010
  Any female-directed emotional IPV in 
course of relationship
79 (33.9%) 50 (57.9%) 129 (40.3%) 0.000
  Any female-directed physical/sexual IPV 
in course of relationship
113 (48.5%) 47 (54.4%) 160 (50.0%) 0.356
  Male partner displays 3 + controlling 
behaviorsc
131 (56.4%) 63 (72.0%) 194 (60.6%) 0.012
  Number of household decisions the 
woman participatesd
3.0 (2.0, 4.0) 2.0 (1.0, 3.0) 2.0 (1.0, 4.0) 0.007
  Woman has greater or equal earnings as 
male partner
59 (25.3%) 17 (19.7%) 76 (23.8%) 0.294
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relationship had 59% lower adjusted odds of early infant 
HIV testing (aOR 0.41; 95% CI 0.21–0.79; p  <  0.01), 
compared to women who did not experience emotional 
IPV. Conversely, women’s participation in household 
decisions was not significantly associated with early 
infant HIV testing, nor was the male partner display-
ing three or more controlling behaviors after adjusting 
for emotional IPV and other control variables. Women 
who reported disclosing their HIV status to the male 
partner, however, had 14 times higher adjusted odds of 
early infant HIV testing (aOR 13.73, 95% CI 3.59–52.49, 
p < 0.001), compared to women who did not disclosure 
their status. Finally, women who reported >80% adher-
ence to ART after birth had 2 times higher adjusted odds 
of early infant HIV testing (aOR 2.28, 95% CI 1.15–4.55, 
p < 0.05), compared to women who reported <80% ART 
adherence and after adjusting for dynamics with the male 
partner and other control variables.
Discussion
Over one-quarter of the HIV-exposed infants in this 
study failed to receive early PCR testing by the recom-
mended 4–6  weeks—hindering early diagnosis and 
treatment, and the odds of survival [3–5]. This study 
demonstrates that dynamics with the male partner may 
have a significant affect on the odds of maternal uptake 
of early infant HIV testing. In this study, female-directed 
emotional IPV was strongly associated with reduced 
adjusted odds of early infant HIV testing. Notably, there 
was a significant interaction between female-directed 
emotional IPV, women’s participation in household deci-
sions, and male partner controlling behaviors—with 
emotional IPV driving the relationship with uptake of 
infant HIV testing. Our findings add to the growing 
body of literature linking different forms of IPV to poor 
medical outcomes across the continuum of care for HIV-
infected mothers and their children [19, 32–34]. Our 
findings also underscore the importance of examining 
IPV as a multidimensional phenomenon [35] and includ-
ing emotional/psychological forms of abuse as potential 
predictors for poor health outcomes.
We hypothesize several potential explanations for 
the relationship between emotional IPV and reduced 
odds of early infant HIV testing, which warrant fur-
ther exploration. First, partners in emotionally violent 
relationships may have poor communication, which is 
known to be important for other PMTCT-related health 
behaviors [36–38]. In addition, male partners who are 
emotionally violent may be less willing to participate in 
PMTCT-related care, which, again, is a known facilita-
tor for uptake of other PMTCT protocols [39–41]. Lastly, 
women experiencing emotional IPV may be afraid of 
finding out the infant is HIV-positive and enduring addi-
tional potential emotional abuse from their male partner. 
We recommend that future qualitative research with per-
ipartum HIV-positive women explore the mechanisms 
within emotionally violent relationships that are different 
than those in physically/sexually violent relationships, 
which may impede the uptake of HIV-related health 
behaviors differentially.
Another dynamic within sexual relationships related 
to early infant HIV testing is women’s HIV status disclo-
sure to male partners. This study supports prior research 
from sub-Saharan Africa indicating women’s HIV sta-
tus disclose to male partners improves participation in 
PMTCT programs [42, 43]. In this study, we document 
a direct quantitative relationship between non-disclosure 
of women’s HIV status to male partners and lower uptake 
of early infant HIV testing. Recent qualitative work 
also indicates that women’s fear of stigma and invol-
untary HIV status disclosure to family members or the 
Table 2 Multiple logistic regression results for  the 
adjusted odds of early infant HIV testing
* p < 0.05; ** p < 0.01;*** p < 0.001




Dynamics with the male partner








 Male partner displays 3 + controlling behaviors 1.05
(0.53–2.06)
 Disclosed HIV status to male partner 13.73***
(3.59–52.49)
Control variables




 Completed secondary education 2.09
(0.81–5.40)
 Standardized wealth Index 1.04
(0.76–1.40)




 Maternal ART adherence postpartum 2.28*
(1.15–4.55)
 Male partner HIV status:
  HIV-Negative ref.
  Unknown 1.68
(0.67–4.19)
  HIV-positive 1.13
(0.58–2.19)
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community are barriers to early infant diagnosis and the 
continuation of HIV care for mothers and their children 
[44, 45].
Outside of dynamics with the male partner, maternal 
HIV-related health behaviors also affect the odds of early 
infant HIV testing. Our findings indicate that women who 
reported better postpartum ART adherence were more 
likely to have their child tested for HIV by 4–6  weeks. 
Importantly, this finding suggests that the HIV-exposed 
children who are at the greatest risk of contracting HIV 
(due to maternal non-adherence to PMTCT) may be least 
likely to be diagnosed through early infant HIV testing. 
It is therefore critical for PMTCT programs to promote 
maternal adherence early in the cascade of care and prior-
itize outreach and counseling with women who are non-
adherent to ART—both for their own health and to ensure 
that they are not lost to follow-up and miss opportunities 
for early infant HIV testing.
Our prior research indicates that IPV against HIV-
positive women, including emotional IPV, negatively 
affects adherence to several steps in the PMTCT cascade, 
including maternal ART adherence during and after 
pregnancy [32]. The present study adds that early infant 
HIV testing, a critical step in the cascade of care for 
HIV-exposed infants, is also affected by emotional IPV. 
Thus, programs within the context of PMTCT that ade-
quately screen for and address various forms of IPV are 
urgently needed. Counseling within PMTCT programs 
should attempt to evaluate women’s home circumstances 
and determine who may be at risk for low compliance 
because of IPV, including emotional abuse. An appropri-
ate referral system between PMTCT programs and IPV 
services should also be prioritized.
The results of this study should be interpreted within 
several limitations. First, it is cross-sectional and cannot 
establish causality or the timing of events. Second, sta-
tus disclosure and gender power dynamics are based on 
self-report, which can be vulnerable to recall and social 
desirability biases. The sample is also non-representative 
and clinic-based, limiting the generalizability of find-
ings. This study may also have selection bias because all 
participants were bringing their children for pediatric 
immunizations, which may not be representative of all 
mother-baby pairs needing infant HIV testing. We did 
not measure communication within the couple or male 
partner support for health behaviors, which may be 
mediating factors in the relationship between emotional 
IPV and uptake of early infant HIV testing. We were also 
unable to test the relationship between dynamics within 
couples and the odds of the infant being diagnosed with 
HIV because only one-third of children had any available 
test results due to the slow turn-around time for PCR in 
Zambia at the time of the study.
Conclusion
This study highlights the role of dynamics within het-
erosexual couples and uptake of early infant HIV 
testing. Emotional IPV and non-disclosure of an HIV-
positive status to male partners are strongly associated 
with reduced odds of early infant HIV testing. Given the 
high prevalence of IPV in the region, including emotional 
IPV, these findings have far-reaching implications for 
early infant HIV diagnosis and treatment. Programs that 
adequately screen for and address various forms of IPV 
within the context of PMTCT are recommended.
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